PET/CT in head and neck cancer: An update

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 645-651

  Hustinx, Roland ^a   Lucignani, Giovanni ^b,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE; O 2 FLUORO ETHYL TYROSINE F 18; TRACER; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOXIA; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT PLANNING; TREATMENT RESPONSE;

HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77949272102     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1365-9     Document Type: Review

References (25)

1. DI Conway M Hashibe P Boffetta INHANCE Consortium V Wunsch-Filho J Muscat C La Vecchia DM Winn 2009 Enhancing epidemiologic research on head and neck cancer: INHANCE-The international head and neck cancer epidemiology consortium Oral Oncol. 45 9 743 6 10.1016/j.oraloncology.2009.02.007 19442571
2. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2009. [Epub ahead of print] doi: 10.3174/ajnr.A1760.
3. H Schöder M Fury N Lee D Kraus 2009 PET monitoring of therapy response in head and neck squamous cell carcinoma J Nucl Med. 50 Suppl 1 74S 88S 10.2967/jnumed.108.057208 19380408
4. HR Chu JH Kim DY Yoon HS Hwang Y Rho 2009 Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases Otolaryngol Head Neck Surg. 141 5 633 8 10.1016/j.otohns.2009.08.008 19861203
5. Sher DJ, Tishler RB, Annino D, Punglia RS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol. 2009. [Epub ahead of print]. doi: 10.1093/annonc/mdp405.
6. S Balogova S Périé K Kerrou D Grahek F Montravers B Angelard B Susini P El Chater JL St Guily JN Talbot 2008 Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma Mol Imaging Biol 10 6 364 73 10.1007/s11307-008-0155-2 1:STN:280: DC%2BD1cnkt1Wrsw%3D%3D 18668293
7. HS Hwang DA Perez LA Orloff 2009 Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer Laryngoscope. 119 10 1958 65 10.1002/lary.20594 19688854
8. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2009. [Epub ahead of print]. doi: 10.1002/hed.21184.
9. RS Rodrigues FA Bozza PE Christian JM Hoffman RI Butterfield CR Christensen M Heilbrun RH Wiggins 3rd JP Hunt BG Bentz YJ Hitchcock KA Morton 2009 Comparison of whole-body FDG-PET/CT, dedicated high-resolution head and neck FDG-PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck J Nucl Med. 50 8 1205 13 10.2967/jnumed.109.062075 19617339
10. MK Chung HS Jeong SG Park JY Jang YI Son JY Choi SH Hyun K Park MJ Ahn YC Ahn HJ Kim YH Ko CH Baek 2009 Metabolic tumor volume of [18F]- fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res. 15 18 5861 8 10.1158/1078-0432.CCR-08-3290 1:CAS:528:DC%2BD1MXhtFars7rM 19737951
11. DA Schinagl AL Hoffmann WV Vogel JA van Dalen SM Verstappen WJ Oyen JH Kaanders 2009 Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Radiother Oncol. 91 1 95 100 10.1016/j.radonc.2009.02.007 19285354
12. H Yu C Caldwell K Mah D Mozeg 2009 Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning IEEE Trans Med Imaging. 28 3 374 83 10.1109/TMI.2008.2004425 19244009
13. H Yu C Caldwell K Mah I Poon J Balogh R MacKenzie N Khaouam R Tirona 2009 Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images Int J Radiat Oncol Biol Phys. 75 2 618 25 19683403
14. Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys. 2009. doi: 10.1016/j.ijrobp.2009.07. 009.
15. P Dirix V Vandecaveye F De Keyzer S Stroobants R Hermans S Nuyts 2009 Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI J Nucl Med. 50 7 1020 7 10.2967/jnumed.109.062638 19525447
16. AG Rabalais R Walvekar D Nuss A McWhorter C Wood R Fields DE Mercante AM Pou 2009 Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy Laryngoscope. 119 6 1120 4 10.1002/lary.20201 19358193
17. JP Malone MA Gerberi S Vasireddy LF Hughes K Rao B Shevlin M Kuhn D Collette J Tennenhouse KT Robbins 2009 Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography Arch Otolaryngol Head Neck Surg. 135 11 1119 25 10.1001/archoto.2009.152 19917925
18. M Yao RB Smith HT Hoffman GF Funk M Lu Y Menda MM Graham JM Buatti 2009 Clinical significance of postradiotherapy FDG-PET imaging in management of head-and-neck cancer-a long-term outcome report Int J Radiat Oncol Biol Phys. 74 1 9 14 1:CAS:528:DC%2BD1MXktl2jsb4%3D 18930358
19. CG Gourin BJ Boyce HT Williams AV Herdman PA Bilodeau TA Coleman 2009 Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer Laryngoscope. 119 11 2150 5 10.1002/lary.20523 19544378
20. H Hoshikawa T Mitani Y Nishiyama Y Yamamoto M Ohkawa N Mori 2009 Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET Auris Nasus Larynx. 36 2 192 8 10.1016/j.anl.2008.05.009 18606510
21. BJ Moeller V Rana BA Cannon MD Williams EM Sturgis LE Ginsberg HA Macapinlac JJ Lee KK Ang KS Chao GM Chronowski SJ Frank WH Morrison DI Rosenthal RS Weber AS Garden SM Lippman DL Schwartz 2009 Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer J Clin Oncol. 27 15 2509 15 10.1200/JCO.2008.19.3300 19332725
22. M Hentschel S Appold A Schreiber A Abramyuk N Abolmaali J Kotzerke M Baumann K Zöphel 2009 Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy Int J Radiat Biol. 85 9 796 804 10.1080/09553000903039180 1:CAS:528:DC%2BD1MXhtVOmsbrE 19728194
23. J Kao HL Vu EM Genden B Mocherla EE Park S Packer PM Som L Kostakoglu 2009 The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer Cancer. 115 19 4586 94 10.1002/cncr.24493 19544537
24. RC Martin M Fulham KF Shannon C Hughes K Gao C Milross MM Tin M Jackson A Clifford MJ Boyer CJ O'Brien 2009 Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer Head Neck. 31 2 244 50 10.1002/hed.20962 19073005
25. N Lee S Nehmeh H Schöder M Fury K Chan CC Ling J Humm 2009 Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys. 75 1 101 8 1:CAS:528: DC%2BD1MXhtVegsLvK 19203843